Morningstar

Grifols SA ADR GRFS

Morningstar Rating

Grifols S.A. (GRFS) Admits Improper Accounting, Announces Restatements, Shares Decline Again – Hagens Berman

Business Wire Aug 2, 2024 5:21pm
GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HBV Treatment, GIGA-2339

GlobeNewswire Jul 31, 2024 12:00pm
Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strengthening its Ig portfolio for patients

GlobeNewswire Jul 29, 2024 12:00pm
Troubled Spanish pharma company Grifols says it may go private for $6 billion

MarketWatch Jul 8, 2024 11:09am
Trending: Grifols Founding Family, Brookfield Eye Takeover Bid for Spanish Drugmaker

Global News Select Jul 8, 2024 10:40am
Grifols Faces Delisting Bid From Founding Family and Brookfield

Global News Select Jul 8, 2024 9:13am
Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years

GlobeNewswire Jul 1, 2024 10:00am
Grifols shares rebound after KPMG greenlights accounts in wake of short-seller's report

MarketWatch Mar 8, 2024 12:05pm
Grifols' shares plunge further on short-seller's new report

MarketWatch Mar 6, 2024 11:30am
Grifols Shares Rise on $1.76 Billion Sale of 20% Stake in Shanghai RAAS to Pay Down Debt

Global News Select Dec 29, 2023 2:44pm

Sponsor Center

Transparency is our policy. Learn how it impacts everything we do

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.

© Copyright 2024 Morningstar, Inc. All rights reserved. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.